title: Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
abstract: MicroRNAs (miRs) function as tumor suppressors or oncogenes in multiple tumor types. Although miR expression is tightly regulated, the molecular basis of miR regulation is poorly understood. Here, we investigated the influence of the histone demethylase Jumonji/ARID1 B (JARID1B) on miR regulation in breast tumor cells. In MCF-7 cells with stable RNAi-mediated suppression of JARID1B expression we identified altered regulation of multiple miRs including let-7e, a member of the let-7 family of tumor suppressor miRs. Chromatin immunoprecipitation analysis demonstrated JARID1B binding to the let-7e promoter region as well as removal of the of H3K4me3 histone mark associated with active gene expression. These results suggest that JARID1B epigenetically represses let-7e expression. JARID1B stimulates tumor cell proliferation by promoting the G(1) to S transition. As predicted, suppression of JARID1B resulted in an accumulation of MCF-7 cells in G(1). We confirmed that cyclin D1, which also promotes G(1) progression, is a direct target of let-7e, and we show that cyclin D1 expression is suppressed in JARID1B knockdown cells. Cyclin D1 expression and cell cycle progression were restored following inhibition of let-7e, suggesting that JARID1B repression of let-7e contributes to cyclin D1 expression and JARID1B-mediated cell cycle progression. Our results indicate that the JARID1B demethylase contributes to tumor cell proliferation through the epigenetic repression of a tumor suppressor miR.
authors.affiliation: Department of Pathology, University of Colorado Denver, Aurora, Colorado 80045, USA.
authors.forename: Doyel
authors.initials: D
authors.lastname: Mitra
authors.forename: Partha M
authors.initials: PM
authors.lastname: Das
authors.forename: Felicia C
authors.initials: FC
authors.lastname: Huynh
authors.forename: Frank E
authors.initials: FE
authors.lastname: Jones
mesh_terms: D001943:Breast Neoplasms / Q000473:pathology*; D002453:Cell Cycle / Q000235:genetics*; D045744:Cell Line, Tumor; D019938:Cyclin D1 / Q000235:genetics; D044127:Epigenesis, Genetic / Q000235:genetics*; D005260:Female; D020868:Gene Silencing; D006657:Histones / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D056484:Jumonji Domain-Containing Histone Demethylases / Q000378:metabolism*; D008239:Lysine; D008745:Methylation; D035683:MicroRNAs / Q000235:genetics*; D009687:Nuclear Proteins / Q000378:metabolism*; D012097:Repressor Proteins / Q000378:metabolism*
chemical_list: D006657:Histones; D035683:MicroRNAs; D009687:Nuclear Proteins; D012097:Repressor Proteins; C487931:mirnlet7 microRNA, human; D019938:Cyclin D1; D056484:Jumonji Domain-Containing Histone Demethylases; C119611:KDM5B protein, human; D008239:Lysine